Valentin Blanchard
St. Paul's Hospital
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review.
Journal: Diabetes & metabolism
Published: June 18, 2025
Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia.
Journal: Clinical nutrition ESPEN
Published: March 15, 2023
Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease.
Journal: Frontiers in genetics
Published: August 06, 2022
Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia.
Journal: Journal of atherosclerosis and thrombosis
Published: June 08, 2022
Smooth Muscle Cell-Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location.
Journal: Frontiers in physiology
Published: April 16, 2022
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
Journal: Circulation. Genomic and precision medicine
Published: February 08, 2022
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms.
Journal: Current atherosclerosis reports
Published: February 04, 2022
Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity.
Journal: Journal of clinical medicine
Published: January 19, 2022
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes.
Journal: Cardiovascular diabetology
Published: November 16, 2021
Macrophages in Atherosclerosis, First or Second Row Players?
Journal: Biomedicines
Published: August 31, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.
Journal: Cardiovascular research
Published: April 28, 2021
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
Journal: Diabetologia
Published: August 04, 2020
Last Updated: 09/26/2026